Global Cancer News

Tasmanian devil research could help tackle immunotherapy resistance


A cluster of interacting proteins that are active in both human cancers and Tasmanian devil facial tumours, may give clues to how cancers evade the immune system. This early work in cells could one day guide us towards new drug combinations that improve the effectiveness of immunotherapy treatments. Researchers at the Peter MacCallum Cancer Centre and University of Melbourne, Australia, in collaboration with scientists in the UK, investigated the reasons why some cancer cells lose proteins from their surface, allowing them to hide from the immune system.


To learn more, see original article at: